Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 24.8.2023Dr. Friedrich Eberth Arzneimittel GmbH (DRF-1)89885Cefotaxim Eberth 2 g (plo jof 10x2 g/50 ml (liek.inj.skl.))1.8.2023O
 24.8.2023B.Braun Melsungen AG (BME)49678Propofol-Lipuro 1 % (10 mg/ml) (emu ijf 1x100 ml/1000 mg (liek.skl.))24.8.2023Z
 24.8.2023B.Braun Melsungen AG (BME)49676Propofol-Lipuro 1 % (10 mg/ml) (emu ijf 1x50 ml/500 mg (liek.skl.))24.8.2023Z
 24.8.2023B.Braun Melsungen AG (BME)72563Aminoplasmal 15 % (sol inf 1x500 ml (fľ.skl.))24.8.2023Z
 24.8.2023B.Braun Melsungen AG (BME)13897Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x250 ml (fľ.PE))8.9.2023R
 24.8.2023B.Braun Melsungen AG (BME)03115Amikacin B.Braun 5 mg/ml (sol inf 10x100 ml/500 mg (fľ.LDPE))24.8.2023O
 24.8.2023Johnson & Johnson, s.r.o. (JHN-SK-1)49919Concerta 18 mg tablety s predĺženým uvoľňovaním (tbl plg 30x18 mg (fľ.HDPE))28.8.2023O
 24.8.2023Sanofi Pasteur (SNP-F-8)92296AVAXIM 160 U (sus iru 1x0,5 ml (striek.inj.skl.))17.8.2023O
 23.8.2023Boehringer Ingelheim International GmbH (BOE)4880DJentadueto 2,5 mg/850 mg filmom obalené tablety (tbl flm 180(3x60x1)x2,5 mg/850 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.))1.9.2023R
 23.8.2023Boehringer Ingelheim International GmbH (BOE)4881DJentadueto 2,5 mg/1000 mg filmom obalené tablety (tbl flm 180(3x60x1)x2,5 mg/1000 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.))1.9.2023Z
 23.8.2023Neuraxpharm Bohemia s.r.o. (NUA)1164DAripiprazole Neuraxpharm 10 mg tablety (tbl 28x10 mg (blis.OPA/Al/PVC/Al))1.7.2023Z
 23.8.2023Neuraxpharm Bohemia s.r.o. (NUA)1172DAripiprazole Neuraxpharm 15 mg tablety (tbl 28x15 mg (blis.OPA/Al/PVC/Al))1.7.2023Z
 23.8.2023Neuraxpharm Bohemia s.r.o. (NUA)1245DDulxetenon 30 mg tvrdé gastrorezistentné kapsuly (cps end 28x30 mg (blis.PA/Al/PVC/Al))1.7.2023Z
 23.8.2023Neuraxpharm Bohemia s.r.o. (NUA)1246DDulxetenon 60 mg tvrdé gastrorezistentné kapsuly (cps end 28x60 mg (blis.PA/Al/PVC/Al))1.7.2023Z
 23.8.2023Neuraxpharm Bohemia s.r.o. (NUA)1855CLamotrigine Neuraxpharm 25 mg tablety (tbl 30x25 mg (blis.PVC/Al))1.7.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)